ACS Laboratory, the largest hemp and cannabis testing facility in the eastern U.S., received 19 Emerald Test Badges in fall 2021 for precise and reliable results. This designation brings the total number of Emerald Test Badges that ACS Laboratory has received to 61 over the past three years, and ranks ACS Laboratory at the top of the U.S. based on Emerald Scientific’s Inter-Laboratory Comparison proficiency test. “ACS has been awarded 61 Emerald Test Badges from 2019 through 2021, continuing our position as the top laboratory in the country. These exceptional results mirror our team’s dedication to accuracy, transparency, and consistency, whether we’re testing oils, flower, edibles, beverages, or topicals,” said Roger Brown, president and founder of ACS Laboratory. The Emerald Test, developed by Emerald Scientific, compares the efficacy of labs like ACS Laboratory to bring a higher level of standardization across the industry. ACS Laboratory passed several tests for accurately detecting contaminants such as residual solvents, heavy metals, molds, and pesticides in hemp and cannabis products including hemp bud, hemp oils and chocolate. “Over the last several years, ACS Laboratory has demonstrated commitment to accuracy in their quality assurance services by fully committing to the Emerald Test,” said Wes Burk, president of Emerald Scientific. “Our industry owes a debt of gratitude to this level of commitment because the cannabis and hemp markets can only thrive on a solid foundation of good science. Emerald Scientific sincerely thanks and congratulates ACS Laboratory on their success and their earning of over 60 Emerald Badges!” ACS Laboratory is on a mission to support cannabis companies in their pursuit to deliver clean, safe, and innovative products that promote positive progress in the industry. Always ahead of the curve, ACS Laboratory is continually enhancing its testing methodologies and developing new tests for harmful toxins, therapeutic terpenes and minor cannabinoids. ACS Laboratory currently analyzes 23 major and minor cannabinoids – an unprecedented quantity for cannabis and hemp testing laboratories in the United States. Due to its expansive capabilities and rigorous protocols, ACS Laboratory has teamed up with medical cannabis companies and research universities nationwide to conduct human trials and pharmacokinetic studies. Due to its success, ACS Laboratory has recently undergone a 20,000 sq. ft. expansion and increased its reach to 48 states and 16 countries worldwide. By ML Staff. Images courtesy of ACS Laboratory

In an era with a heavy emphasis on digital means, many people are delving into digital currency. Since the inception of Bitcoin in 2009, more than a decade later, the popularity and demand for cryptocurrency has significantly increased. This week, many of those cryptocurrency gurus will meet in South Fla. for Miami NFT Week from April 1 to 3 and Bitcoin Conference 2022 from April 6 to 9. In honor of the conferences’ takeover of Miami, here is the ultimate guide to Miami restaurants and hotels where crypto enthusiasts can pay with digital currency. Restaurants MAMEY Mamey by chef Niven Patel, 4x James Beard nominee and Food and Wine Best Chef class of 2020, is a chic farm-to-table restaurant serving clever cuisine with Asian, Caribbean & Polynesian influences. Through the property’s partnership with BitPay, Mamey allows guests the opportunity to utilize Bitcoin, Bitcoin Cash, Ethereum, Dogecoin and four USD-pegged stablecoins (GUSD, USDC, PAX and BUSD) to pay for dining. ORNO Orno, by chef Niven Patel, a 4x James Beard nominee and Food and Wine Best Chef class of 2020, is a New American restaurant that offers guests a true, farm-to-table experience using locally sourced ingredients from Chef Patel's very own farm, Rancho Patel. Chef Patel’s wood-fired culinary creations are complimented by specialty cocktails and hand selected wines. Orno allows guests the opportunity to utilize Bitcoin, Bitcoin Cash, Ethereum, Dogecoin and four USD-pegged stablecoins (GUSD, USDC, PAX and BUSD), guests can use cryptocurrency to pay for dining. CHOTTO MATTE The global restaurant Chotto Matte brings Miami Beach a taste of Nikkei cuisine, with flavors and ingredients that tastefully blend Japanese and Peruvian culinary traditions. The restaurant is launching its first ever NFT in conjunction with NFT Week and Bitcoin Conference on April 5. From April 4 - 10, Chotto Matte will serve a limited edition, Bitcoin-inspired cocktail, the 10/31, featuring Hakushu 12-year-old Japanese Whisky, Cognac, Umeshu Okinawa black sugar and bitters, and a secret set menu, both only available for purchase in Bitcoin. The theatrical drink will be presented with a flammable dollar garnish and flamed in front of the guest, then revealing a Bitcoin coin. Chotto Matte’s secret menu, featuring opulent dishes like a Wagyu Sirloin, will only be available to those with "Whales" and "Industry" passes. Hotels SHELBORNE SOUTH BEACH Shelborne South Beach, an Art Deco gem, is conveniently located on the iconic Ocean Drive and boasts an amazing Oasis Garden, David’s Cafe (a Miami favorite for Cuban coffee) and iconic Art Deco pool deck for a relaxed vibe and traditional South Beach nostalgia. Shelborne partners with BitPay to accept cryptocurrency payments on its websites, by email, or in person. THESIS HOTEL THesis Hotel Miami is a modern property located in Coral Gables, offering guests a sun-filled rooftop pool with tropical views and a poolside bar. THesis Hotel was the first hotel in the Miami area and one of the first nationwide to accept cryptocurrency as payment. Through its partnership with BitPay, THesis Hotel Miami allow guests the opportunity to utilize Bitcoin, Bitcoin Cash, Ethereum, Dogecoin and four USD-pegged stablecoins (GUSD, USDC, PAX and BUSD) to pay for room reservations, dining and event bookings.

Psychedelic Invest, an online resource educating stakeholders about the burgeoning psychedelic medicine industry, is pleased to announce the launch of the Psychedelic Invest Podcast. The company, which is a subsidiary of the holdings company, Nucleus, will be releasing one new podcast episode per week for ten weeks. With episodes currently running, season one of the podcast is slated to conclude on June 29. After which, a second season will be released, which is already being recorded. The Psychedelic Invest Podcast is hosted by entrepreneur, business coach, and plant medicine enthusiast, Bruce Eckfeldt. The podcast is formatted around an interview series highlighting one personality, leader or organization per episode. The interviews range from 30 to 60 minutes in length and touch on the many facets of how psychedelic medicines will continue to permeate the mainstream and popular culture; and how that will affect investors, business leaders, and adjacent industries. The first episode showcased Zappy Zapolin, psychedelic concierge to the stars, where he discussed his thoughts on how ketamine will change the world. Season one also includes interviews with the following industry professionals: Dr. Chris Witowski: CEO of Psilera Bioscience Nanea Reeves: CEO of Tripp Jason Hein: Researcher at University of British Columbia Danny Moytyka: CEO of Psygen Hadas Alterman: Founding Partner at Plant Medicine Law Group Charles Patti: Brand Ambassador at My Self Wellness In addition to the Psychedelic Invest Podcast, the company plans to unveil a handful of content programs throughout the rest of 2022. On that list are ‘The Investor Hotseat’ and the continuation of ‘The Psychedelic Series’; both hosted by Dustin Robinson, founder of Iter Investments. Nucleus, the parent company of Psychedelic Invest, also plans to continue presenting in-person events throughout the year. “All of this forthcoming content from Psychedelic Invest, combined with our latest version of our data platform, Neuly, and everything we’re building at Nucleus as a whole, is allowing us to satisfy our mission of destigmatizing psychedelic medicines,” stated Nucleus CEO, Logan Lenz. “We’re going to continue to build infrastructure around reliable data that fuels high-quality educational content. Doing so consistently over time is always the best way to push a movement forward.” “The global mental health crisis is one of the largest challenges that the world is facing right now, and people are looking for information on how psychedelics can help,” said Robinson. “Our mission at Nucleus is to make the data and tools available to guide people on their mental health journey, and these podcast episodes and programs continue to help lead the conversation about the importance of psychedelics.” The Psychedelic Invest Podcast is available to stream and/or download at https://psychedelicinvest.com/podcast and everywhere podcasts are available. New episodes are available every Wednesday. For more information about Psychedelic Invest, please visit www.psychedelicinvest.com. For more information about Nucleus, please visit www.withnucleus.com. By ML Staff. Images courtesy of The Psychedelic Invest Podcast

In an effort to give the cannabis community an opportunity to safely connect, engage, learn and grow; Durée & Company, Inc. has organized the virtual panel discussion, “USDA Final Rule for Hemp Production: What Does This Mean For You?,” hosted by Cannabis LAB (CLAB). On Thursday, April 8, 2021, starting at 6:00 p.m., the panelists will discuss how this rule will impact different facets of the cannabis industry, as well as speak to the trending cannabinoid, Delta-8 THC. The USDA’s final rule surrounding hemp production regulations went into effect March 22, 2021. In short, the program provides requirements for maintaining records about the land where hemp is produced, testing the levels of total Delta-9 THC, disposing of non-compliant plants, licensing hemp producers, and ensuring compliance under the new program. Durée Ross, CEO of Durée & Company, a public relations, marketing and special events firm that serves many clients in the cannabis, hemp and CBD industries; will moderate a panel of experts. The panel will weigh in on the new USDA hemp rules, and provide participants with key takeaways to keep them current with the regulations. The panel includes: Masha Belinson, corporate development with ACS Laboratory; Dustin Robinson, founding partner of Mr. Cannabis Law; Ricardo Alvares, regional director of South Florida for the Florida Department of Agriculture and Consumer Services (FDACS); and Jason Navarrete, CEO and founder of Pure Craft CBD. Virtual via Zoom, the event is free for CLAB members. Non-CLAB members can participate in the virtual event or watch the recording by purchasing a ticket for $20. To RSVP, participants may visit: www.eventbrite.com/e/usda-final-rule-for-hemp-production-what-does-this-mean-for-you-tickets-148270465955?aff=ebdssbonlinesearch. To sign up for a CLAB membership, visit www.joinclab.com/membership. By ML Staff. Image courtesy of Unsplash

Enjoy Hemp, an industry leader of hemp-derived Delta-8 THC products, has launched new Delta-8 THC gummies, available in both 750mg and 1500mg, in response to growing consumer demand. Enjoy Hemp is the first and only line of premium hemp-derived Delta-8 THC products designed for customers to “enjoy life” how they choose. Enjoy Hemp’s gummies are the only experienced-based edibles on the market. The Delta-8 THC gummies are available in the following experiences and flavors: Relief Delta-8 THC Gummies (Strawberry) – this blend of anti-inflammatory terpenes infused in Enjoy Hemp’s hybrid blend of strawberry gummies may help consumers with stress. Euphoria Delta-8 THC Gummies (Blue Raspberry) – this blend of Sativa terpene-infused blue raspberry gummies will have users headed to a state of euphoria. Uplift Delta-8 THC Gummies (Mango) – this blend of Sativa terpene-infused gummies in mango may help consumers with the perfect daytime or uplifting blend. Relaxation Delta-8 THC Gummies (Pineapple) – this blend of Indica terpenes infused in Enjoy Hemp’s pineapple gummies may help users chill and relax. Providing 50mg per gummy, the 750mg, 15-count is available for $39.99 and the 1500mg, 30-count is $59.99 – the most affordable price per milligram on the market. Enjoy Hemp formulates its products to offer the effects and experiences consumers desire such as relaxation, energy, relief, euphoria, etc. Each of Enjoy Hemp’s product formulations are proprietarily formulated to provide the effects and experiences consumers are looking for with the effect of each item displayed on the front for ease of purchase. “Enjoy Hemp embraces ‘enjoying life,’ and we’re happy to give our customers more chances to do just that by offering the most affordable Delta-8 THC gummies on the market,” said Enjoy Hemp co-founder Adam Levit. “Our experienced-based edibles are not only delicious, but they allow customers to enjoy life the way they want to, and at higher quantities than most Delta-8 offerings.” All Enjoy Hemp's products are manufactured in Bend, Oregon. The state provides optimal growing conditions for hemp because of its agricultural and climate conditions. To ensure transparency to its customers, Enjoy Hemp’s products are third-party laboratory tested by certified independent laboratories and have a Certificate of Analysis (COA) correlated to the lot number of each product. The company tests every product for cannabinoid and terpene content, as well as heavy metals, pesticides, residual solvents, and microbials. To view and/or purchase Enjoy Hemp’s Delta-8 THC gummies, visit https://enjoyhemp.co/d8gummies/. By ML Staff. Image courtesy of Enjoy Hemp

ACS Laboratory, the largest hemp and cannabis testing facility in the Eastern half of the U.S., was just awarded 21 Emerald Test Badges for accurate and reliable results. This accomplishment marks ACS Laboratory’s fourth consecutive year as the Emerald Scientific Inter-Laboratory Comparison proficiency test’s leading badge recipient. “ACS Laboratory now holds 82 total proficiency testing badges, more than any laboratory in the USA. Our stellar performances illustrate our unwavering commitment to accountability and precision across leading hemp and cannabis products,” said Roger Brown, president of ACS Laboratory. Emerald Scientific’s Emerald Test compares laboratories’ testing abilities by sending each facility the same samples to test and comparing their results against each other and the ISO 13528:2017 industry standard. Laboratories whose results fall within the accepted range receive proficiency awards. This fall, ACS Laboratory received badges for potency testing. Additionally, ACS Laboratory passed several tests for accurately detecting harmful contaminants such as heavy metals, pesticides, bacteria, yeast, mold, and mycotoxins in oils, chocolates, and flower. Every year, ACS Laboratory enrolls in Emerald Scientific’s inter-laboratory comparison test to ensure it ranks among the nation’s top third-party laboratories driving this industry forward. ACS Laboratory’s latest 21-badge achievement proves it continues to raise the bar on quality standards, guaranteeing consumers receive safe, clean, and accurately labeled products. ACS Laboratory currently analyzes 23 major, minor and novel cannabinoids, including HHC, THCO, and THCP. It also provides more than 30 safety, quality, and R&D tests across hemp and cannabis. ACS Laboratory is one of the only laboratories nationwide to offer HHC and THCO-specific safety bundles, scanning for residual acids and metals that could remain in these products post-production. To support its multi-state hemp clients, ACS Laboratory recently launched a National Hemp Panel. ACS Laboratory’s chemists built the Panel to meet every state testing requirement, ensuring nationwide brands can legally and safely sell high-quality products across the country. “We look forward to another successful year for our team and clients, providing safe, cutting-edge products to consumers and patients,” said Brown. By ML Staff. Images courtesy of ACS Laboratory

ACS Laboratory, in combination with 3Chi, is partnering with Blockticity to launch the first national hemp client Certificate of Analysis (COA) as a non-fungible token (NFT). The NFT drop will go live during Art Basel Miami Beach 2021 – Art Basel’s first in-person fair in Miami Beach since 2019 – and Miami Art Week, which takes place from December 2-4, 2021. ACS Laboratory, the largest hemp and cannabis testing facility in the eastern U.S., is the first laboratory to authenticate COAs on a blockchain. Partnering with Blockticity (https://blockticity.io/), the leader in guaranteed certificates of authenticity, as well as Moonwalk (https://www.moonwalk.com/), the leading NFT platform, is a dream team collaboration that will revolutionize the way COAs are accepted, processed, and distributed. “ACS Laboratory is proud to release the first ever Certificate of Analysis (COA) on the blockchain and the first ever non-fungible token (NFT) for that COA on the blockchain,” said Roger Brown, President of ACS Laboratory. “We always strive to be at the forefront of new technology and cutting edge cannabis laboratory testing technology.” “The blockchain is the future for cannabis and hemp to secure the integrity of the analytical results and the COA, determine permissions and eventually to include payments,” Brown continued. This will be a limited NFT release. Instructions and more information will be provided on ACS Laboratory’s Facebook, Instagram and Twitter pages. About ACS Laboratory The Most Trusted Cannabis and Hemp Laboratory in the USA™, ACS Laboratory earned 42 Emerald Test Badges for accuracy in testing in 2019 and 2020; more than any other laboratory in the USA. ACS Laboratory is ISO 17025 accredited, DEA licensed and CLIA licensed with the largest state-of-the-art facility in the USA. Compliant with the USDA’s rules for hemp testing, ACS is also approved by the Florida Department of Agriculture as a “Designated Compliance Laboratory,” and deemed a "Certified Marijuana Testing Laboratory" by the Florida Department of Health. Due to its success, ACS Laboratory has undergone a 20,000 sq. ft. expansion and increased its reach to 48 states and 13 countries worldwide. Beyond compliance, ACS is committed to innovation, which is why it tests for more cannabinoids than any lab in the country and continuously develops new protocols to analyze lesser-known toxins. Its facility utilizes industry-leading ultra-high-performance liquid chromatography-tandem mass spectrometry and gas chromatograph technology with proprietary protocols to ensure accurate detection and quantitation. Watch this video about ACS Laboratory, and read the blog for up-to-date information on cannabis science and lab testing for both the hemp and cannabis industries. For more information, visit acslab.com, or call (561) 510-8396. About 3Chi The premier national hemp brand, 3Chi was founded by a biochemist with 15 years of product formulation experience who witnessed the healing powers of hemp firsthand. 3Chi is focused on cannabinoid research and bringing minor cannabinoids to market in an effort to create the most effective products available today. After developing a new way to make a pure version of Delta-8 THC from hemp in September 2019, 3Chi was able to offer the USA’s first federally legal THC-dominant product since cannabis prohibition started. From that point on, they have been the leading CBN and Delta-8 distributor in the United States, offering a range of THC and CBD products for all of recreational and medicinal needs. For more information, visit https://www.3chi.com/. About Blockticity The leader in guaranteed certificates of authenticity for the most valuable possessions. A different approach to credibility with error-proof certifications through blockchain verification technology. Blockticity is providing the platform for the first ever cannabis and hemp industry blockchain verified certificate of analysis NFT drop to signify the beginning of this emerging industry's need for compliance! For more information, visit https://blockticity.io/.

Enjoy Hemp, the first and only line of premium hemp-derived products designed for customers to “enjoy life” how they choose, has launched a line of Delta-9 THC gummies, available in four different effects: Boost, Chill, Euphoria and Zen. For the first time in history, consumers are able to get dispensary grade Delta-9 THC products delivered to their homes or at their local store without a medical card. As an industry leader and best-seller, Enjoy Hemp released these revolutionary products to address the needs of many storefronts and consumers who rely on Enjoy Hemp’s Delta-8 THC products. Consumers will not have to worry about receiving their favorite Enjoy Hemp products with the possibility of Delta-8 THC being banned, because these Delta-9 THC products are compliant with the 2018 Farm Bill. Delta-9 THC, a cannabinoid molecule, is the main psychoactive ingredient in marijuana. Enjoy Hemp's Delta 9 THC gummies are legal in all 50 states under the 2018 Farm Bill because the products are derived from hemp and contain a Delta-9 THC concentration of not more than 0.3 percent on a dry weight basis. Similar to Enjoy Hemp’s other products, each product is specifically formulated with a specific terpene blend to target each desired effect. The 250mg, 25-count gummies come in assorted fruit flavors and are available for $34.99. The Delta-9 THC gummies are available in the following experiences: Boost Delta-9 THC Gummies: Enjoy Hemp’s Sativa enhanced Delta-9 THC Boost gummies contain Sativa terpenes, terpinol and alpha-pinene, which are known for their energetic and uplifting effects. Chill Delta-9 THC Gummies: Enjoy Hemp’s blend of Indica terpene-infused Delta-9 THC gummies aim to bring the consumer to a state of relaxation. Euphoria Delta-9 THC Gummies: Enjoy Hemp’s blend of Sativa terpene-infused Delta-9 THC gummies are created with the terpenes alpha-pinene and limonene to bring consumers to a state of euphoria. Zen Delta-9 THC Gummies: Enjoy Hemp’s blend of mood-boosting, terpene-infused Delta-9 THC gummies contain the terpenes limonene and ocimene that can potentially help relieve stress and anxiety while boosting one’s mood to feel nothing but Zen. “Our experience-based edibles have been a big hit with our consumers, and we’re excited to add the Delta-9 THC gummies to our line-up,” said EnjoyHemp co-founder Adam Levit. “These Delta-9 THC gummies will allow consumers to purchase dispensary grade Delta-9 THC products delivered to their homes or at their local store without a medical card.” Enjoy Hemp’s products are vegan, all-natural, and gluten-free. Each of its product formulations are proprietarily formulated to provide the effects and experiences consumers are looking for with the effect of each item displayed on the front for ease of purchase. To ensure transparency to its customers, Enjoy Hemp’s products are third-party laboratory tested by certified independent laboratories and have a Certificate of Analysis (COA) correlated to the lot number of each product. The company tests every product for cannabinoid and terpene content, as well as heavy metals, pesticides, residual solvents, and microbials. All Enjoy Hemp's products are manufactured in Bend, Oregon. The state provides optimal growing conditions for hemp because of its agricultural and climate conditions. To view and/or purchase Enjoy Hemp’s Delta-9 THC gummies, visit https://enjoyhemp.co/shop-by-category/delta-9-thc-fully-compliant/delta-9-thc-gummies-terpenes/. By ML Staff. Images courtesy of Enjoy Hemp

Miami residents, neighborhood and homeowners' associations, and businesses—including some founded by Norman Braman—have brought a legal action to stop a back door deal between City officials and a local development group paving the way for casino gambling throughout the City of Miami. According to Norman Braman, "The latest filing is a motion to intervene in the federal case in which a bogus lawsuit was 'settled' through a sweetheart deal and as an end around the zoning code.  The City and West Flagler were on the same side," Mr. Braman said, "leaving Miami citizens on the outside whose interests were otherwise trampled on by City officials." The motion filed by Mr. Braman and other Miami residents property owners seeking to make certain that the federal court does not enforce any "settlement" while the residents' state court lawsuit proceeds to invalidate the underlying interpretation of City code on which the federal "settlement" explicitly relies. "We regret to be forced to file this motion to protect the right of all Miami residents to have a say as to whether Miami should allow gambling," said Norman Braman, who has opposed gambling and championed voter participation in Miami for over 30 years.  "But we have an obligation to preserve our rights," he continued. "West Flagler's claimed right to have a jai alai fronton in Edgewater is a 2012 letter issued in secret and obtained without any notice or process. If the City of Miami is going to allow gambling—and I've long said it should not—then notice must be given to Miami's residents so that they can have a meaningful say and hold elected officials responsible." "It's unfortunate that the City Attorney and West Flagler entered into this settlement approving a gambling facility in the midst of the ongoing health crisis. But the pandemic will not prevent Miami's citizens from protecting their quality of life or from ensuring the City's long-term prosperity. We will take those actions necessary to protect our rights, and we hope the City Attorney and West Flagler refrain from further action towards advancing a gambling facility while the public is focused on more important issues." The proposed Intervenors, including businesses founded by Mr. Braman, are represented by Stearns Weaver Miller. By Stearns Weaver Miller

For almost a year, Dustin Robinson, Esq. CPA has been hosting a monthly Psychedelic Series at Soho Beach House Miami. Due to the high demand of his Psychedelic Series, Robinson is partnering with Space Park Miami to host “Psychedelic Medicine: The Future of Mental Health” on Saturday, February 19 at 5:30 p.m. Dr. Michelle Weiner Presented by Nucleus and LinkMiamiRebels, Michelle Weiner, DO, MPH, psychedelic expert at Spine and Wellness Centers of America, and Zappy Zapolin, psychedelic concierge to the stars and founder of KetaMD, will join Robinson for this free panel to discuss the progress in medicine with the help of psychedelics. At the event, attendees will learn firsthand how psychedelics are paving the way to many medicinal advancements. The panel will follow the 4:20 p.m. Space Park Yoga class. Dr. Michelle Weiner is double board-certified in Interventional Pain Medicine and Physical Medicine and Rehabilitation. Dr. Weiner focuses on diagnosing and treating spine and musculoskeletal pain as well as chronic migraines at the Spine and Wellness Centers of America. Her unique approach of personalized and preventative medicine focuses on empowering her patients to cultivate health using lifestyle and plant medicine. Her research focuses on using cannabis as a substitute for opioids in chronic pain patients and cannabis’ effect on seniors with chronic pain. Dr. Weiner is the Vice President of Mr. Psychedelic Law and on the Advisory Board for Iter Investments. She uses cannabis and ketamine-assisted psychotherapy as a catalyst to identify the root cause of one’s suffering, optimizing their quality of life. Zappy is often called on as a “psychedelic concierge” to help celebrities, thought leaders and business icons have a conscious transformation. Known as a visionary and futurist, Zappy has been spotting trends for decades such as internet domain names, legal CBD and cannabis, and now the burgeoning psychedelic economy. Zappy is the founder of Mind Army, The Ketamine Fund and KetaMD. Zappy’s documentary, “Lamar Odom Re/Born,” features Lamar Odom’s complete transformation from public breakdown, depression, and addiction to healthy and thriving through ketamine infusions and plant medicine. Robinson is Founding Partner of Mr. Cannabis Law – a full service law firm focused on the cannabis and psychedelic industries; Co-Founder of Mr. Psychedelic Law – a non-profit focused on psychedelic legal reform; and Managing Principal of Iter Investments – a venture capital firm deploying capital across the psychedelic ecosystem. Along with Iter Investments, he recently launched Nucleus, a data-driven psychedelics platform that is focused on mental health data and technologies. The event free and open to the public, ages 18 and up. To RSVP, please visit: https://www.eventbrite.com/e/psychedelic-medicine-the-future-of-mental-health-tickets-266434090537 Where: Space Park Miami 298 NE 61 Street, Miami, FL 33137 By ML Staff. Image courtesy of Dustin Robinson

Nucleus, a South Florida startup focused on mental health data and technologies, today announced its launch. The company, which is wholly owned by the venture capital firm, Iter Investments, is unveiling an entire ecosystem designed to meet people where they are and support them on their mental health journey. The platform is centered around a unique search engine experience, which provides ample space for the self-discovery process to play out safely and effectively. Nucleus is made up of technology, data, and media assets intended to deliver intelligence, education, and opportunities to those that are looking for a resource for self-discovery and industry information. Within the platform, participants can assess their emotional health, find treatments, journal their experiences, and fully own all of their documented health data along the way. This is all in an effort to give the power back to patients so they can better understand themselves as they grow and evolve. Attached to Nucleus is a constellation of companies feeding the ecosystem with even more resources while providing participants with an array of opportunities. The list of assets include: Neuly: A subscription-based data platform for researchers and professionals in the psychedelics and mental health industry Psychedelic Invest: A resource equipping investors with reports and insights spanning the growing industry of plant, entheogenic, and psychoactive medicines Matter Academy: A collection of training programs for wellness practitioners Psyrise: A marketing partner for mental health brands Particles: A decentralized community building the future of well-being The creation of Nucleus first began when Iter Investments acquired Psychedelic Invest and Neuly in June of 2021. Managing Principal of Iter Investments Dustin Robinson explains, “Nucleus’ acquisition of Psychedelic Invest and Neuly provided Nucleus the foundation for building a robust ecosystem that captures data and disseminates it to the broad and growing psychedelic audience.” Since then, the collective team of developers, researchers, and writers have been in stealth mode working to expand the Nucleus universe in order to help as many people as possible. Serial tech and marketing entrepreneur, Logan Lenz, later joined as CEO of Nucleus to lead the way during the company's ascent. Over the past 20 years, Lenz has founded several startups and worked with brands such as Disney, Coca-Cola, and Planet Fitness on their media plans. Then, after over a decade of building solutions himself, Logan became a consultant and advisor to many startups in the healthcare space. Billions of dollars of marketing and advertising spend later, Lenz has garnered a portfolio of success stories ranging from blockchain development to IPOs. Recently, Psychedelic Invest, utilizing the vast database of Neuly, launched its 2021 Year-in-Review Report – a 100-page example of the deep analytical capabilities of both the platform and the team. In addition, Neuly has undergone a redesign and an upgrade to ensure its maintaining the most robust, secure, and reliable data in the industry. In the near future, Lenz has plans for Nucleus to launch an NFT collection with the community and is finalizing a blockchain bridge that will allow clinics and therapists to integrate health records with the platform and store everything on-chain. "Over the next few years, I believe we're going to start to see the future of well-being unfold right before our eyes,” said Lenz. Nucleus is well-positioned to serve as a foundational layer to what can eventually become a decentralized system for healthcare." Robinson continued, "The global mental health crisis is arguably the largest challenge the world is facing right now. The world is suffering and people need information and support. Nucleus can assist all industry stakeholders including patients, clinicians, therapists, practitioners, investors, advocates, and psychedelic companies in some way - all while collaborating and helping to propel the entire industry forward." For more information, please visit www.withnucleus.com. By ML Staff. Image courtesy of Unsplash

For almost a year, Dustin Robinson, Esq. CPA has been hosting a monthly Psychedelic Series at Soho Beach House Miami. As a result of the series’ success, Robinson is partnering with Space Park Miami to host “Psychedelic Medicine: The Future of Mental Health” on Saturday, April 16. Presented by Nucleus and LinkMiamiRebels, Michelle Weiner, DO, MPH, psychedelic expert at Spine and Wellness Centers of America, and Julia Mirer, MD, consultant in the emerging field of psychedelic medicine, will join Robinson for this free panel to discuss the progress in medicine with the help of psychedelics. At the event, attendees will learn firsthand how psychedelics are paving the way for many medicinal advancements. The panel will follow the 4:20 p.m. Space Park Yoga class. Dr. Michelle Weiner is double board-certified in Interventional Pain Medicine and Physical Medicine and Rehabilitation. Dr. Weiner focuses on diagnosing and treating spine and musculoskeletal pain as well as chronic migraines at the Spine and Wellness Centers of America. Her unique approach of personalized and preventative medicine focuses on empowering her patients to cultivate health using lifestyle and plant medicine. Her research focuses on using cannabis as a substitute for opioids in chronic pain patients and cannabis’ effect on seniors with chronic pain. Dr. Weiner is the Vice President of Mr. Psychedelic Law and on the Advisory Board for Iter Investments. She uses cannabis and ketamine-assisted psychotherapy as a catalyst to identify the root cause of one’s suffering, optimizing their quality of life. Dr. Julia Mirer is a consultant in the emerging field of psychedelic medicine, serving as a bridge between eastern and western practices, committed to merging them to help create a new paradigm for integrative health and wellness. She was on the road to a career in pediatrics, but decided to shift gears to explore transformative medicine where she has found her calling in education and advocacy for the responsible use of these medicines. Dr. Mirer believes that a successful future for this field depends on the interplay between policy, research, and clinics and has therefore positioned herself to play a role in each. Nationally, she is an advisor for the Psychedelic Medicine Coalition, lobbying for NIH funding for psychedelic research. In Florida, she is a facilitator for FDA clinical trials with psychedelics. Most recently, Dr. Mirer joined Nushama as director of strategy, where she hopes to combine all her experience to create the vision of a new kind of healthcare system and facilitate Nushama’s goal of humanizing medicine. Robinson is Founding Partner of Mr. Cannabis Law; Co-Founder of Mr. Psychedelic Law; and Managing Principal of Iter Investments. Along with Iter Investments, he recently launched Nucleus, a data-driven psychedelics platform that is focused on mental health data and technologies. The event free and open to the public, ages 18 and up. To RSVP, visit https://www.eventbrite.com/e/psychedelic-medicine-the-future-of-mental-health-tickets-320965194537. By ML Staff. Image courtesy of Dustin Robinson